From: Prognostic significance of tumor markers in T4a gastric cancer
Factors (n) | 5-year survival (%) | Log-rank χ2 | P |
---|---|---|---|
AFP | 6.287 | 0.012 | |
≥10 (16) | 25.0 | ||
<10 (257) | 38.9 | ||
CEA | 58.940 | 0.000 | |
≥10 (44) | 11.4 | ||
<10 (229) | 43.2 | ||
CA19-9 | 131.705 | 0.000 | |
≥37 (89) | 10.1 | ||
<37 (184) | 51.6 | ||
CA50 | 104.377 | 0.000 | |
≥20 (81) | 13.6 | ||
<20 (192) | 48.4 | ||
Sex | 0.001 | 0.978 | |
Male (192) | 38.5 | ||
Female (81) | 37.0 | ||
Age (years) | 4.300 | 0.038 | |
≤40 (26) | 23.1 | ||
>40 (247) | 39.7 | ||
Tumor site | 11.754 | 0.008 | |
Upper (90) | 34.4 | ||
Middle (52) | 34.6 | ||
Lower (124) | 43.5 | ||
≥Two-third (7) | 14.3 | ||
Tumor size | 8.687 | 0.003 | |
≤6 (178) | 42.7 | ||
>6 (95) | 29.5 | ||
Borrmann type | 10.158 | 0.017 | |
I (15) | 40.0 | ||
II (8) | 50.0 | ||
III (228) | 39.0 | ||
IV (22) | 22.7 | ||
N stage | 62.666 | 0.000 | |
N0 (49) | 67.3 | ||
N1 (49) | 53.1 | ||
N2 (52) | 44.2 | ||
N3 (123) | 17.9 | ||
Nervous invasion | 17.848 | 0.000 | |
+ (197) | 29.9 | ||
-(76) | 59.2 | ||
Lymphovascular invasion | 17.242 | 0.000 | |
+ (196) | 30.6 | ||
-(77) | 57.1 | ||
Adjuvant chemotherapy | 1.443 | 0.230 | |
Yes (223) | 39.0 | ||
No (50) | 34.0 |